Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice.
Saved in:
| Title: | Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice. |
|---|---|
| Authors: | Cambier A; Service de Néphrologie pédiatrique-hémodialyse, CHU Sainte Justine, Montréal, Canada.; Axe Maladies immunitaires et cancer, Centre de Recherche Azrieli, Université de Montréal, CHU Sainte Justine, Montréal, Canada.; Centre d'expertise sur les maladies rares médiées par le complément, CHU Sainte Justine, Montréal, Canada., Da Silva J; Université de Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM U1149 & CNRS E8252, Inflamex Laboratory of Excellence, Paris, France., Bex J; Université de Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM U1149 & CNRS E8252, Inflamex Laboratory of Excellence, Paris, France., Canesi F; Université de Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM U1149 & CNRS E8252, Inflamex Laboratory of Excellence, Paris, France., Neanne LL; Centre d'expertise sur les maladies rares médiées par le complément, CHU Sainte Justine, Montréal, Canada., Sannier A; Université de Paris Cité, Service anatomopathologie, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France., Mathieu H; Axe Maladies immunitaires et cancer, Centre de Recherche Azrieli, Université de Montréal, CHU Sainte Justine, Montréal, Canada.; Centre d'expertise sur les maladies rares médiées par le complément, CHU Sainte Justine, Montréal, Canada., Boedec E; Université de Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM UMR1266, Biochemistry and Biophysics facility, Paris, France., Badie A; Axe Maladies immunitaires et cancer, Centre de Recherche Azrieli, Université de Montréal, CHU Sainte Justine, Montréal, Canada.; Centre d'expertise sur les maladies rares médiées par le complément, CHU Sainte Justine, Montréal, Canada., Monteiro RC; Université de Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM U1149 & CNRS E8252, Inflamex Laboratory of Excellence, Paris, France. |
| Source: | PloS one [PLoS One] 2025 Oct 07; Vol. 20 (10), pp. e0318581. Date of Electronic Publication: 2025 Oct 07 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41056297 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cambier+A%22">Cambier A</searchLink>; Service de Néphrologie pédiatrique-hémodialyse, CHU Sainte Justine, Montréal, Canada.; Axe Maladies immunitaires et cancer, Centre de Recherche Azrieli, Université de Montréal, CHU Sainte Justine, Montréal, Canada.; Centre d'expertise sur les maladies rares médiées par le complément, CHU Sainte Justine, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Da+Silva+J%22">Da Silva J</searchLink>; Université de Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM U1149 & CNRS E8252, Inflamex Laboratory of Excellence, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bex+J%22">Bex J</searchLink>; Université de Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM U1149 & CNRS E8252, Inflamex Laboratory of Excellence, Paris, France.<br /><searchLink fieldCode="AU" term="%22Canesi+F%22">Canesi F</searchLink>; Université de Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM U1149 & CNRS E8252, Inflamex Laboratory of Excellence, Paris, France.<br /><searchLink fieldCode="AU" term="%22Neanne+LL%22">Neanne LL</searchLink>; Centre d'expertise sur les maladies rares médiées par le complément, CHU Sainte Justine, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Sannier+A%22">Sannier A</searchLink>; Université de Paris Cité, Service anatomopathologie, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mathieu+H%22">Mathieu H</searchLink>; Axe Maladies immunitaires et cancer, Centre de Recherche Azrieli, Université de Montréal, CHU Sainte Justine, Montréal, Canada.; Centre d'expertise sur les maladies rares médiées par le complément, CHU Sainte Justine, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Boedec+E%22">Boedec E</searchLink>; Université de Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM UMR1266, Biochemistry and Biophysics facility, Paris, France.<br /><searchLink fieldCode="AU" term="%22Badie+A%22">Badie A</searchLink>; Axe Maladies immunitaires et cancer, Centre de Recherche Azrieli, Université de Montréal, CHU Sainte Justine, Montréal, Canada.; Centre d'expertise sur les maladies rares médiées par le complément, CHU Sainte Justine, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Monteiro+RC%22">Monteiro RC</searchLink>; Université de Paris Cité, Centre de Recherche sur l'Inflammation (CRI), INSERM U1149 & CNRS E8252, Inflamex Laboratory of Excellence, Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2025 Oct 07; Vol. 20 (10), pp. e0318581. <i>Date of Electronic Publication: </i>2025 Oct 07 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41056297 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0318581 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0318581 Titles: – TitleFull: Blockade of mTOR ameliorates IgA nephropathy by correcting CD89 and CD71 dysfunctions in humanized mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cambier A – PersonEntity: Name: NameFull: Da Silva J – PersonEntity: Name: NameFull: Bex J – PersonEntity: Name: NameFull: Canesi F – PersonEntity: Name: NameFull: Neanne LL – PersonEntity: Name: NameFull: Sannier A – PersonEntity: Name: NameFull: Mathieu H – PersonEntity: Name: NameFull: Boedec E – PersonEntity: Name: NameFull: Badie A – PersonEntity: Name: NameFull: Monteiro RC IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 10 Text: 2025 Oct 07 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 20 – Type: issue Value: 10 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |